These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37356982)

  • 21. Treatment of severe aplastic anemia with antilymphocyte globulin and androgens: a report on 33 patients.
    Facon T; Walter MP; Fenaux P; Morel P; Dupriez B; Gardin C; Jouet JP; Bauters F
    Ann Hematol; 1991 Aug; 63(2):89-93. PubMed ID: 1912037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.
    Peinemann F; Bartel C; Grouven U
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD006407. PubMed ID: 23881658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome.
    Rosenfeld S; Follmann D; Nunez O; Young NS
    JAMA; 2003 Mar; 289(9):1130-5. PubMed ID: 12622583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study.
    Atta EH; Dias DS; Marra VL; de Azevedo AM
    Ann Hematol; 2010 Sep; 89(9):851-9. PubMed ID: 20373101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclosporine plus eltrombopag in the treatment of aplastic anemia with or without antithymocyte immunoglobulin: A multicenter real-world retrospective study.
    Chen M; Liu Q; Gao Y; Suo X; Ding X; Wang L; Li L; Shao Y; Gao D; Sun W; Tan Y; Wang W; Ye F; Han B
    Eur J Haematol; 2023 Sep; 111(3):407-413. PubMed ID: 37271577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO).
    Bacigalupo A; Bruno B; Saracco P; Di Bona E; Locasciulli A; Locatelli F; Gabbas A; Dufour C; Arcese W; Testi G; Broccia G; Carotenuto M; Coser P; Barbui T; Leoni P; Ferster A
    Blood; 2000 Mar; 95(6):1931-4. PubMed ID: 10706857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the prognostic factors of very severe aplastic anemia treated with Chinese Kidney-invigorating drugs in combination with anti-lymphocyte globulin or anti-thymocyte globulin.
    Tang XD; Liu F; Li L; Liu C; Zhang SS; Xiao HY; Zheng CM; Xu S; Ma R
    Chin J Integr Med; 2012 Jan; 18(1):40-5. PubMed ID: 22160947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of aplastic anemia with an investigational antilymphocyte serum prepared in rabbits.
    Stein RS; Means RT; Krantz SB; Flexner JM; Greer JP
    Am J Med Sci; 1994 Dec; 308(6):338-43. PubMed ID: 7985721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of childhood aplastic anemia with antithymocyte globulin, management of side effects and long-term follow-up].
    Fu XY; Xie XT; Jiang SY; Shi W; Shao YX
    Zhonghua Er Ke Za Zhi; 2011 Mar; 49(3):226-30. PubMed ID: 21575376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of rabbit antithymocyte globulin and Jurkat cell-reactive anti-T lymphocyte globulin as a first-line treatment for children with aplastic anemia.
    Xie X; Shi W; Zhou X; Shao Y; Qiao X
    Exp Hematol; 2014 Jun; 42(6):431-8. PubMed ID: 24582815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet/Lymphocyte ratio independently predicts the outcome of severe aplastic anemia patients treated with antithymocyte globulin.
    Dong P; Ge M; Wu H; Ren X; Huo J; Li X; Zheng Y
    Rev Assoc Med Bras (1992); 2021 Mar; 67(3):378-384. PubMed ID: 34468601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A long-term follow up study on 345 severe aplastic anemia patients treated with antithymocyte globulin/lymphoglobulin].
    Shao YQ; Li XX; Ge ML; Shi J; Zhang J; Huang JB; Huang ZD; Nie N; Zheng YZ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jan; 34(1):30-5. PubMed ID: 23597461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of two types of antithymocyte globulin in the treatment of children with aplastic anemia].
    Xie XT; He W; Shi W; Zhou XX; Qiao XH
    Zhonghua Er Ke Za Zhi; 2016 Apr; 54(4):294-8. PubMed ID: 27055431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of the clinical manifestations of COVID-19 in patients with aplastic anemia undergoing immunosuppressive therapy: a prospective cohort study (NICHE)].
    Zhao JY; Zhang LL; Kuang ZX; Xu J; Wang WW; Pan H; Gao Z; Li WW; Fang LW; Song Z; Shi J
    Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):900-905. PubMed ID: 38185518
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
    Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A;
    Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of porcine ALG and rabbit ATG on outcomes of HLA-haploidentical hematopoietic stem cell transplantation for patients with acquired aplastic anemia.
    Chen J; Zhang Y; Chen X; Pang A; Zhao Y; Liu L; Ma R; Wei J; He Y; Yang D; Zhang R; Zhai W; Ma Q; Jiang E; Han M; Zhou J; Feng S
    Cancer Cell Int; 2022 Feb; 22(1):89. PubMed ID: 35189891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Results of severe aplastic anemia treated with antilymphocytic globulin].
    Morales-Polanco MR; Pizzuto-Chávez J; Izquierdo-Ramírez J; Farfán-Canto JM
    Gac Med Mex; 1989; 125(3-4):97-101; discussion 102-4. PubMed ID: 2633949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithymocyte globulin/antilymphocyte globulin plus kidney-nourishing Chinese medicinal: effect on severe aplastic anemia.
    Tang X; Liu F; Li L; Liu C; Zhang S; Xiao H; Zheng C; Xu S; Ma R
    J Tradit Chin Med; 2012 Dec; 32(4):604-8. PubMed ID: 23427396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.